NACDS Marketplace In Brief: Novartis Tavist Sinus
This article was originally published in The Tan Sheet
Executive Summary
Novartis Tavist Sinus: Advertising campaign, supported by about $5 mil., will kick off with TV ads in early October. A free-standing insert is scheduled to drop in newspapers nationwide on Oct. 19, followed by another in January. No print ads are planned; some regional radio ads may be aired. The monograph acetaminophen/pseudoephedrine combo, comparable to McNeil's Sine-Aid and Warner-Lambert's Sinutab, will ship Aug. 1 ("The Tan Sheet" May 19, p. 10). Tavist-D caplets, a line extension to Tavist-D tablets, also will ship Aug. 1...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning